Cyclophosphamide versus mycophenolate mofetil in scleroderma interstitial lung disease (SSc-ILD) as induction therapy: a single-centre, retrospective analysis
Scleroderma is a systemic autoimmune disease characterized mainly by skin manifestations and involvement of various visceral organs, especially the lungs. Lung involvement is the leading cause of mortality in ...
Source: Arthritis Research and Therapy - Category: Rheumatology Authors: Padmanabha D. Shenoy, Manish Bavaliya, Sujith Sashidharan, Kaveri Nalianda and Sreelakshmi Sreenath Source Type: research
More News: Arthritis | Autoimmune Disease | Interstitial Lung Disease | Rheumatology | Scleroderma | Skin